Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Alkermes Plc (NQ: ALKS )

22.85 USD +0.48 (+2.15%)
Official Closing Price Updated: 4:02 PM EST, Jan 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Alkermes Plc

< Previous 1 2 3 4 5 6 7 8 9
...
53 54 Next >
NIDA-Funded Study Evaluating Extended-Release Injectable Naltrexone Plus Bupropion for the Treatment of Methamphetamine Use Disorder Published in New England Journal of Medicine
Results from a National Institute on Drug Abuse (NIDA)-funded study evaluating the efficacy and safety of naltrexone for extended-release injectable suspension (XR-NTX) administered once every three... 
From PR Newswire
The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags CLPT Guidance ALDX
From Benzinga
Notable Thursday Option Activity: ENPH, CREE, ALKS
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Enphase Energy Inc. (ENPH), where a total volume of 31,652 contracts has been... 
Tags Stocks
From Market News Video
Alkermes to Present at the 39th Annual J.P. Morgan Healthcare Conference
Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will provide a corporate overview and update at the 39th Annual J.P. Morgan Healthcare Conference. The... 
From PR Newswire
Alkermes Announces Updates to Executive Leadership Team
-- Blair C. Jackson Appointed Chief Operating Officer and Iain M. Brown Named Chief Financial Officer, Positioning Company for Continued Strong Execution of Business Strategy -- 
From PR Newswire
Thinking about buying stock in Immersion Corp, IRIDEX Corp, One Stop Systems, Phio Pharmaceuticals, or Alkermes?
InvestorsObserver issues critical PriceWatch Alerts for IMMR, IRIX, OSS, PHIO, and ALKS. 
From PR Newswire
The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Biotech OPT QLGN
From Benzinga
FDA Accepts Alkermes' Resubmission of New Drug Application for ALKS 3831
- FDA Sets PDUFA Target Action Date of June 1, 2021 - 
From PR Newswire
Alkermes Shares Resources for Opioid Addiction
Tags Opioid Abuse and Addiction Improving Healthcare Access Alkermes
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Biotech Stocks To Watch: This Drug Firm With Key Decision Ahead Is In Buy Zone
The IBD Stock Spotlight is shining on Alkermes stock. It is currently one of the top biotech stocks to watch as it hits a new buy point. 
From Investor's Business Daily
Notable Wednesday Option Activity: BLK, ALKS, CME
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Blackrock Inc (BLK), where a total of 3,498 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
Resources for Those Managing Alcohol Use Disorder This Holiday Season
Tags Wellness Health & Healthcare Responsible Business & Employee Engagement
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Provides Tips for Managing Holiday Stress
Tags Alkermes Improving Healthcare Access Mental Health
From 3BL Media: Corporate Social Responsibility, Energy and Health News
First Week of August 2021 Options Trading For Alkermes (ALKS)
Investors in Alkermes plc (ALKS) saw new options become available this week, for the August 2021 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is... 
Tags Stocks
From Market News Video
The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags BNR XTLB OCX
From Benzinga
Stocks That Hit 52-Week Highs On Monday
Monday's morning session saw 240 companies set new 52-week highs. Key Facts: The largest company by market cap to ... 
Tags Health Care JOE CDXS
From Benzinga
Stocks That Hit 52-Week Highs On Friday
This morning 167 companies reached new 52-week highs. Noteables: Walt Disney (NYSE: DIS) was the largest firm on a ... 
Tags WAL FTDR BG
From Benzinga
84 Biggest Movers From Yesterday
Gainers SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) shares climbed 176.4% to close at $17.66 on Thursday after climbing 73% on ... 
Tags EDSA Trading Ideas PTGX
From Benzinga
Noteworthy Thursday Option Activity: ALKS, CVS, TDOC
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Alkermes plc (ALKS), where a total of 4,442 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
Here's Why Alkermes Shares Jumped Higher Today
The biotech has a plan to increase profitability. 
Tags ALKS Market News
From Motley Fool
60 Stocks Moving In Thursday's Mid-Day Session
Gainers Immutep Limited (NASDAQ: IMMP) shares jumped 198.6% to $6.42 after the company said its Chinese partner,EOC Pharma ... 
Tags SLCA SLS VERU
From Benzinga
Alkermes Jumps 11% After Reaching Agreement With Activist Elliott
Shares of Alkermes are moving higher after the company announced a "Value Enhancement Plan" and cooperation agreement with activist Elliott Advisors. 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
Alkermes Announces Strategic Value Enhancement Plan and Continued Board Refreshment
- Commits to Non-GAAP Net Income Margin Targets of ~25% for FY 2023 and ~30% for FY 2024, Reflecting Rigorous Expense Management, Expected Revenue Growth and Commitment to Shareholder Value Creation - 
From PR Newswire
3 Ways The COVID-19 Pandemic Is Actually Hurting Some Healthcare Stocks
Not everything is coming up roses for the industry. 
Tags SPPI BMY MDT
From Motley Fool
Alkermes Celebrates Giving Tuesday with Alkermes in Action Program
Tags Alkermes Volunteering Social Impact & Volunteering
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Attention Biotech Investors: Mark Your Calendar For Dec. PDUFA Dates
The U.S. Food and Drug Administration's approval machinery churned out a lot of disappointments in November. Most of the negative verdicts were tied to difficulties the agency had in inspecting... 
Tags Stocks / Equities Pharma/Biotech Healthcare
From Blogs - TalkMarkets
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
The U.S. Food and Drug Administration'sapproval machinery churned out a lot of disappointments in November. Most of the ... 
Tags MYOV SNY Government
From Benzinga
The Week Ahead In Biotech: Moderna Vaccine And Roche, Revance, Rhythm, Liquidia FDA Updates
Biotech stocks came under pressure in the week ended Nov. 20, reversing course from the previous week. The sector started the week on a ... 
Tags SNY Earnings GLTO
From Benzinga
The Daily Biotech Pulse: Setback For Alkermes, Boston Scientific's Recall, ALX-Zymeworks Oncology Collaboration
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Biotech JAGX UTHR
From Benzinga
Alkermes Receives FDA Complete Response Letter Related to ALKS 3831 Manufacturing Records Review
-- No Clinical Efficacy or Safety Issues Raised and No Further Studies Required by FDA to Support Approval -- 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
53 54 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.